70 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
and commercial operations, as well as increases in professional services and consulting costs. These increases were partially offset by decreased costs … of the embedded derivative liability associated with deferred royalty obligation, partially offset by an increase in non-cash interest expense related
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
B.V. and increased costs associated with headcount, certain clinical trials, pre-clinical studies and gene sequencing and was partially offset … to support business and commercial operations in the United Sates and internationally, professional services and other expenses and was partially offset
8-K
EX-10.1
igy9151r
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.2
1ixax7se
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.4
rra5 2i7oa6ta96c
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.3
dje ypqxiz4rlwza5
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-99.1
tfugf8j6bf16l7d ijs
1 Aug 23
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business
7:05am
8-K
EX-99.1
cvpanzfx5ce
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
dk9wciout0bs
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am
424B5
n1kf15k1
15 Sep 22
Prospectus supplement for primary offering
4:00pm
424B5
65sp8r6bj0
14 Sep 22
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
ndvkcwi6b
2 Aug 22
Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update
7:02am